Introduction: Sindhu Ramchandren, M.D., M.S.

Welcome to the Ramchandren research site! Here you will find information on our clinics and research.

I am a Neurologist specializing in Neuromuscular Disorders, and the Director of the Muscular Dystrophy Associataion (MDA) Clinic at the University of Michigan.  I completed my Medical training at the University of Texas-Houston, my Neurology residency at the University of Pennsylvania, my Fellowship in Clinical Neurophysiology- EMG at Johns Hopkins University under Dr. David Cornblath and Dr. Vinay Chaudhry, and a Master of Science in Clinical Research and Statistics at the University of Michigan, as a post-doctoral Research Fellow under Dr. Eva Feldman.  

From 2008-2013, I was an Assistant Professor at Wayne State University, where I had the privilege to work with and learn from giants in the field of Neuromuscular Disease- Dr. Mike Shy, Dr. Rich Lewis, and Dr. Bob Lisak.  I joined the University of Michigan's Neurology Department in 2013, and I currently direct the University of Michigan’s Muscular Dystrophy Association (MDA) Multidisciplinary clinics.  The Charcot-Marie-Tooth Association (CMTA) has recognized our CMT clinic as one of 10 Centers of Excellence in clinical and research care in the United States.  I am a proud member of the Institute for Healthcare Policy and Innovation, the Palatucci Advocacy Leadership Forum (class of 2015), and the Women's Issues in Neurology Section at the American Academy of Neurology. 

I am currently funded by the NIH (K23-NS072279) to develop a disease-specific QOL measure for children with CMT, through a longitudinal assessment of children enrolled in the Inherited Neuropathy Consortium.  My research mission is to identify and analyze the factors contributing to increased disease burden in patients with genetic neuromuscular diseases, using my background as a physician-scientist with advanced training in neurology, neuromuscular disease and pathology, EMG, clinical research design and statistical analysis.  Understanding the constructs underlying disease burden will help identify directed interventions that improve the quality of life and functional status of patients with genetic neuromuscular disease.

Contact me at, or click on the links below to learn more about my research.